DiaMedica Therapeutics Inc.
Equity & Debt
| Period | Long Term Debt | Share Holder Equity | Cash on Hand |
|---|---|---|---|
| Dec 2016 | — | $1.1M | — |
| Dec 2017 | — | $799.0K | $1.4M |
| Mar 2018 | — | $6.7M | $6.7M |
| Jun 2018 | — | $5.4M | $5.7M |
| Sep 2018 | — | $4.1M | $3.9M |
| Dec 2018 | — | $17.0M | $16.8M |
| Mar 2019 | — | $13.9M | $2.8M |
| Jun 2019 | — | $11.7M | $3.0M |
| Sep 2019 | — | $9.7M | $4.7M |
| Dec 2019 | — | $7.6M | $3.9M |
| Mar 2020 | — | $13.3M | $3.3M |
| Jun 2020 | — | $11.3M | $5.0M |
| Sep 2020 | — | $29.8M | $9.8M |
| Dec 2020 | — | $26.0M | $7.4M |
| Mar 2021 | — | $23.1M | $3.3M |
| Jun 2021 | — | $20.3M | $2.2M |
| Sep 2021 | — | $47.0M | $16.2M |
| Dec 2021 | — | $44.0M | $4.7M |
| Mar 2022 | — | $40.8M | $3.0M |
| Jun 2022 | — | $37.7M | $3.1M |
| Sep 2022 | — | $35.1M | $2.8M |
| Dec 2022 | — | $31.8M | $4.7M |
| Mar 2023 | — | $27.0M | $2.1M |
| Jun 2023 | — | $59.7M | $5.8M |
| Sep 2023 | — | $55.6M | $2.2M |
| Dec 2023 | — | $51.1M | $4.5M |
| Mar 2024 | — | $46.3M | $2.1M |
| Jun 2024 | — | $53.4M | $14.1M |
| Sep 2024 | — | $48.0M | $4.1M |
| Dec 2024 | — | $40.7M | $3.0M |
| Mar 2025 | — | $34.0M | $2.6M |
| Jun 2025 | — | $27.2M | $4.1M |
| Sep 2025 | — | $51.6M | $3.3M |
| Dec 2025 | — | $56.1M | $15.6M |
| Mar 2026 | — | $47.2M | $4.9M |
| Jun 2026 | — | $38.3M | $5.1M |